Related Experiment Video
Updated: May 19, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia
Benjamin L Shneider1, John C Magee, Jorge A Bezerra
1Department of Pediatrics, Children’s Hospital Pittsburgh of UPMC, Pittsburgh, PA 15224, USA. benjamin.shneider@chp.edu
Insights
Fat-soluble vitamin deficiencies are common in infants with biliary atresia (BA), even with TPGS-FSV preparation. Persistent cholestasis and high bilirubin levels indicate a need for individualized vitamin supplementation and monitoring in BA infants.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Nutritional Science
Background:
- Cholestasis in infants, particularly those with biliary atresia (BA), significantly increases the risk of fat-soluble vitamin (FSV) deficiencies.
- A common clinical practice involves administering a liquid multiple FSV preparation containing tocopheryl polyethylene glycol-1000 succinate (TPGS) due to its ease of use and perceived effectiveness.
Purpose of the Study:
- To prospectively assess the prevalence of FSV deficiencies in infants diagnosed with BA who were receiving a TPGS-based FSV preparation.
- To evaluate the relationship between FSV levels, serum total bilirubin (TB), and outcomes in infants with BA.
Main Methods:
- A prospective, multicenter study involving 92 infants with BA.
- Infants received a TPGS-containing FSV preparation alongside routine clinical care during a trial for corticosteroid therapy post-hepatoportoenterostomy (HPE).
- Measurements of FSV levels, retinol binding protein, total serum lipids, and TB were conducted at 1, 3, and 6 months post-HPE.
Main Results:
- Biochemical evidence of FSV insufficiency was prevalent across all measured vitamins (A, D, K, E) at all time points.
- Vitamin levels demonstrated an inverse correlation with serum TB levels.
- FSV insufficiency was significantly more common in infants with TB levels ≥2 mg/dL, with many showing complete insufficiency at later time points.
Conclusions:
- Despite the administration of a TPGS-containing FSV preparation, biochemical FSV insufficiency remains a common issue in infants with BA and persistent cholestasis.
- Individualized vitamin supplementation strategies and diligent monitoring are crucial for managing FSV status in infants with BA, especially those with elevated TB levels (≥2 mg/dL).
Objective:
Cholestasis predisposes to fat-soluble vitamin (FSV) deficiencies. A liquid multiple FSV preparation made with tocopheryl polyethylene glycol-1000 succinate (TPGS) is frequently used in infants with biliary atresia (BA) because of ease of administration and presumed efficacy. In this prospective multicenter study, we assessed the prevalence of FSV deficiency in infants with BA who received this FSV/TPGS preparation.
Methods:
Infants received FSV/TPGS coadministered with additional vitamin K as routine clinical care in a randomized double-blinded, placebo-controlled trial of corticosteroid therapy after hepatoportoenterostomy (HPE) for BA (identifier NCT 00294684). Levels of FSV, retinol binding protein, total serum lipids, and total bilirubin (TB) were measured 1, 3, and 6 months after HPE.
Results:
Ninety-two infants with BA were enrolled in this study. Biochemical evidence of FSV insufficiency was common at all time points for vitamin A (29%-36% of patients), vitamin D (21%-37%), vitamin K (10%-22%), and vitamin E (16%-18%). Vitamin levels were inversely correlated with serum TB levels. Biochemical FSV insufficiency was much more common (15%-100% for the different vitamins) in infants whose TB was ≥2 mg/dL. At 3 and 6 months post HPE, only 3 of 24 and 0 of 23 infants, respectively, with TB >2 mg/dL were sufficient in all FSV.
Conclusions:
Biochemical FSV insufficiency is commonly observed in infants with BA and persistent cholestasis despite administration of a TPGS containing liquid multiple FSV preparation. Individual vitamin supplementation and careful monitoring are warranted in infants with BA, especially those with TB >2 mg/dL.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Vitamins
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test